Research on transcription of mRNA of inducible NO synthase and supression of its degradation by proinflammatory cytokine.
| Project/Area Number |
11672172
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | University of Tokushima |
|---|
Principal Investigator |
HISAYAMA Tetsuhro Univ. of Tokushima, Fac. Pharmaceut. Sci., Associate Professor, 薬学部, 助教授 (70130383)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HORIO Shuhei Univ. of Tokushima, Fac. Pharmaceut. Sci., Assistent Professor, 薬学部, 助手 (80145010)
FUKUI Hiroyuki Univ. of Tokushima, Fac. Pharmaceut. Sci., Professor, 薬学部, 教授 (90112052)
|
|---|
| Project Period (FY) |
1999 – 2000
|
| Project Status |
Completed (Fiscal Year 2000)
|
| Budget Amount *help |
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2000: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1999: ¥1,800,000 (Direct Cost: ¥1,800,000)
|
|---|
| Keywords | vascular smooth muscle / TRAF6 / enzyme induction / proinflammatory cytokine / interleukin 1 / messenger RNA stability / p38 MAPkinase / inducible NO synthase / 一酸化窒素 / 形質導入 |
|---|
| Research Abstract |
In this research, we have carried out molecular cloning of TRAF6 involved in interleukin 1 (IL-1)-mediated expression of inducible nitric oxide synthase (iNOS), construction of its gene transfer system, and investigation on mechanisms of suppression of iNOS mRNA degradation via activation of IL-1 receptors. The transient expression of TRAF6 resulted in enhancement of the IL-1-induced iNOS mRNA production, while inhibited nuclear translocation of NF-kB by IL-1, suggesting a possibility that NF-kB could not necessarily mediate the IL-1-induced expression of the iNOS gene. Further, we for the first time, found that IL-1 suppressed a degradation of iNOS mRNA, and that p38 MAPkinase is involved in its signal transduction pathway. IL-1 selectively induced a double-phosphorylation of p38, but not on ERK or JNK, other subfamily of MAPkinases, and expression of a specific activator of p38, namely a constitutively activated variant of MKK6, suppressed a degradation of iNOS mRNA without application of IL-1. These results open a clue for development of new drugs and remedies against inflammatory diseases, and contribute to understanding of pathophysiological basis of proinflammatory cytokines.
|
Report
(3 results)
Research Products
(3 results)
